ipilimumab,nivolumab
bms,delcath systems
['focus trial', 'chopin']
positive initial results from chopin phase 1b trial, focus trial update and qol study presented at the 2022 asco annual meeting 
A Cure In Sight is a non-profit organization founded to raise Ocular Melanoma awareness and to help OM patients find/pay for the treatments that they need.